A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
Clinical trial NCT05155007 · COMPLETED
Trial details
- NCT number
- NCT05155007
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2022-02-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.